GKB Ophthalmics Limited (BOM:533212)
64.84
+1.14 (1.79%)
At close: Jun 4, 2026
GKB Ophthalmics Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 48.97 | 30.21 | 32.32 | 23.64 | 58.94 |
Short-Term Investments | - | 99.15 | 139.76 | 117.5 | 99.2 |
Trading Asset Securities | - | 0.01 | 0.01 | 0.01 | 0.01 |
Cash & Short-Term Investments | 48.97 | 129.37 | 172.09 | 141.15 | 158.14 |
Cash Growth | -62.15% | -24.82% | 21.92% | -10.75% | -6.61% |
Accounts Receivable | 448.67 | 254.92 | 283.99 | 277.39 | 195.07 |
Other Receivables | - | 3.38 | 1.58 | 11.47 | 6.35 |
Receivables | 448.67 | 258.29 | 285.58 | 288.86 | 201.42 |
Inventory | 546.31 | 503.78 | 400.19 | 387.4 | 377.04 |
Prepaid Expenses | - | 11.14 | 7.14 | 6.21 | 5.31 |
Other Current Assets | 35.66 | 91.32 | 9.78 | 11.7 | 13.44 |
Total Current Assets | 1,080 | 993.9 | 874.77 | 835.31 | 755.35 |
Property, Plant & Equipment | 186.06 | 209.37 | 221.2 | 229.78 | 260.6 |
Long-Term Investments | 19.53 | 20.12 | 18.29 | 18.88 | 19.69 |
Other Intangible Assets | 1.86 | - | 0.01 | 0.02 | 0.04 |
Other Long-Term Assets | 34.6 | 28.76 | 30.73 | 36.87 | 65.9 |
Total Assets | 1,322 | 1,252 | 1,145 | 1,121 | 1,102 |
Accounts Payable | 562.91 | 392.88 | 330.94 | 237.94 | 255.66 |
Accrued Expenses | - | 35.48 | 24.3 | 22.46 | 18.49 |
Short-Term Debt | 100.8 | 94.79 | 99.87 | 96.46 | 96.2 |
Current Portion of Long-Term Debt | - | 19.36 | 4.48 | 4 | 5.19 |
Current Unearned Revenue | - | 80.79 | 0.44 | 47.25 | 1.96 |
Other Current Liabilities | 48.17 | 0.56 | 2.24 | 2.79 | 9.44 |
Total Current Liabilities | 711.88 | 623.86 | 462.27 | 410.9 | 386.93 |
Long-Term Debt | 15.75 | 30.82 | 10.52 | 11.7 | 16.16 |
Pension & Post-Retirement Benefits | - | 33.1 | 30.18 | 23.07 | 20.65 |
Long-Term Deferred Tax Liabilities | - | - | - | - | 1.59 |
Other Long-Term Liabilities | 45.16 | - | - | 2.23 | 2.09 |
Total Liabilities | 772.79 | 687.78 | 502.97 | 447.89 | 427.42 |
Common Stock | 50.41 | 50.41 | 50.41 | 50.41 | 50.41 |
Additional Paid-In Capital | - | 206.71 | 205.28 | 204.45 | 200.24 |
Retained Earnings | - | 306.37 | 369.79 | 393.71 | 372.98 |
Comprehensive Income & Other | 477.93 | -43.1 | -27.77 | -21.63 | 7.33 |
Total Common Equity | 528.33 | 520.39 | 597.71 | 626.93 | 630.96 |
Minority Interest | 20.55 | 43.98 | 44.32 | 46.04 | 43.2 |
Shareholders' Equity | 548.88 | 564.37 | 642.03 | 672.97 | 674.16 |
Total Liabilities & Equity | 1,322 | 1,252 | 1,145 | 1,121 | 1,102 |
Total Debt | 116.55 | 144.96 | 114.87 | 112.16 | 117.55 |
Net Cash (Debt) | -67.59 | -15.59 | 57.22 | 28.99 | 40.6 |
Net Cash Growth | - | - | 97.36% | -28.59% | -18.19% |
Net Cash Per Share | -13.42 | -3.09 | 11.35 | 5.75 | 8.05 |
Filing Date Shares Outstanding | 5.09 | 5.04 | 5.04 | 5.04 | 5.04 |
Total Common Shares Outstanding | 5.09 | 5.04 | 5.04 | 5.04 | 5.04 |
Working Capital | 367.73 | 370.04 | 412.5 | 424.42 | 368.41 |
Book Value Per Share | 103.81 | 103.24 | 118.58 | 124.38 | 125.18 |
Tangible Book Value | 526.47 | 520.39 | 597.7 | 626.91 | 630.92 |
Tangible Book Value Per Share | 103.44 | 103.24 | 118.58 | 124.37 | 125.17 |
Land | - | 5.32 | 5.38 | 5.32 | 5.02 |
Buildings | - | 56.6 | 56.6 | 56.56 | 79.17 |
Machinery | - | 425.12 | 416.37 | 396.49 | 381.56 |
Construction In Progress | - | 39.06 | 39.06 | 39.45 | 34.13 |